Antibiotic treatment with Penicillin reduces rheumatic heart disease progression

Published On 2021-11-19T16:16:17+05:30 | Updated On 19 Nov 2021 10:46 AM GMT

Overview

A regular, affordable antibiotic treatment significantly reduced the risk of underlying rheumatic heart disease progression in children and adolescents, according to a new study.

The research, led by the Murdoch Children's Research Institute (MCRI), Cincinnati Children's Hospital Medical Center, Uganda Heart Institute and the Children's National Hospital in Washington, also showed that early screening was critical in preventing serious rheumatic heart disease progression and death in young children.

For more details, check out the full story on the link below:

Secondary Antibiotic Prophylaxis With Penicillin Reduces Rheumatic Heart Disease Progression: NEJM

Speakers

Dr. Nandita Mohan

Dr. Nandita Mohan is a practicing pediatric dentist with more than 3 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped.